Iopidine 1% — Cigna
control or prevention of post-surgical elevations in intraocular pressure after argon laser trabeculoplasty, argon laser iridotomy or Nd:YAG posterior capsulotomy
Preferred products
- apraclonidine 0.5% ophthalmic solution (generic)
- brimonidine tartrate 0.1% ophthalmic solution (generic)
- brimonidine tartrate 0.15% ophthalmic solution (generic)
- brimonidine tartrate 0.2% ophthalmic solution (generic)
Initial criteria
- If the patient has tried one Step 1 Product, approve a Step 2 Product.
- If the patient is undergoing argon laser trabeculoplasty, argon laser iridotomy or Nd:YAG posterior capsulotomy, approve Iopidine 1%.
Approval duration
1 year